4//SEC Filing
LAUER REGAN J 4
Accession 0001326110-23-000149
CIK 0001326110other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 4:41 PM ET
Size
7.6 KB
Accession
0001326110-23-000149
Insider Transaction Report
Form 4
LAUER REGAN J
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-15+21,030→ 74,932 total - Exercise/Conversion
Restricted Stock Units
2023-12-15−21,030→ 21,031 total→ Common Stock (21,030 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F2]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the restricted stock units ("RSUs") will vest as follows: 1/3rd of the RSUs subject to the award shall vest June 15, 2023, 1/3rd of the RSUs subject to the award shall vest December 15, 2023, and 1/3rd of the RSUs subject to the award shall vest December 15, 2024 such that the award shall be fully vested on December 15, 2024.
Documents
Issuer
ImmunityBio, Inc.
CIK 0001326110
Entity typeother
Related Parties
1- filerCIK 0001200637
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 4:41 PM ET
- Size
- 7.6 KB